Research on Chronic Pain Treatment with Human-Derived Mesenchymal Stem Cell Conditioned Medium

未提供0 个研究点目标入组 100 人开始时间: 待定

适应症

试验速览

暂无简介。

•1. Individuals who did not experience satisfactory pain relief effects with standard therapy.
•2. Individuals who do not wish to undergo treatment with drugs commonly used in standard therapy due to concerns about side effects, and whose physicians have determined that treatment with conditioned medium is appropriate for chronic pain relief.
•Patients meeting the following criteria are eligible:
•1. Individuals aged 18 years or older.
•2. Individuals with normal capacity to consent.
•3. Individuals who have been provided with the informed consent document for this treatment, have received sufficient explanation, and are capable of providing written consent freely and voluntarily.
•4. Individuals for whom the attending physician has recognized the necessity of treatment.

发起方

未提供